Venus MedTech has acquired 2 companies, including 1 in the last 5 years.
Venus MedTech’s largest acquisition to date was in 2021, when it acquired Cardiovalve for $300M. Venus MedTech has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include medical products (100%).
No. 88, Jiangling Road Room 311, 3/F Block 2 Binjiang District,
Hangzhou,
310051
China,
0571-87772180
www.venusmedtech.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2021-12-07 |
Cardiovalve · Medical Products
Or Yehuda, Israel · www.cardiovalve.com Cardiovalve is a transcatheter mitral and tricuspid valve treatment company that manufactures replacement products for patients suffering from mitral or tricuspid regurgitation. Cardiovalve was founded in 2010 and is based in Or Yehuda, Israel. |
300 | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
